- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
- 10-K Annual report
- 10.4.1 Exhibit 10.4.1 Master Note Amendment
- 10.6 Exhibit 10.6 Form of Eight Percent Convertible Debenture
- 10.7 Exhibit 10.7 Revised Master Loan Agreement
- 10.8 Exhibit 10.8 Employment Agreement with Steven C. Eror
- 10.9 Exhibit 10.9 Employment Agreement with Michael Garff
- 21.1 Exhibit 21.1 List of Subsidiaries
- 31.1 Exhibit 31.1 Section 302 Certification
- 31.2 Exhibit 31.2 Section 302 Certification
- 32.1 Exhibit 32.1 Section 906 Certification
- 32.2 Exhibit 32.2 Section 906 Certification
- Download Excel data file
- View Excel data file
Exhibit 32.1
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Annual Report on Form 10-K of Fresh Medical Laboratories, Inc. (the “Company”) for the year ended December 31, 2013, as filed with the Securities and Exchange Commission (the “Report”), I, Steven Eror, President and Chief Executive Officer of the Company, hereby certify pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:
1.
The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
2.
The information contained in this Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
Dated: | April 3, 2014 | /s/ Steven Eror |
|
| Steven Eror |
|
| Chief Executive Officer |